Whole-body bioelectrical impedance analysis in assessing upper-limb lymphedema after breast cancer therapy.
The purpose of this prospective study was to evaluate single-frequency whole-body bioelectrical impedance analysis (BIA) as a predictor for the onset of edema of the upper limb in patients undergoing treatment for breast cancer. Whole-body BIA was performed before surgery, as well as at two days, and one, three, six and twelve months after surgery. Sixty women undergoing breast cancer surgery were examined, with loss of follow-up of 18 patients. Seven patients (14.3%) developed an edema of the upper limb within the first 12 months after surgery. Resistance (R) using whole-body BIA showed a fairly good performance in terms of sensitivity (85.71%) and specificity (97.4%) at predicting edema. The positive predictive value of 54.6% was unsatisfactory, whereas the negative predictive value was 97.4%. Resistance in whole-body BIA can be used to rule-out a developing edema of the upper limb.